Breaking News Updates for the Psychedelics Industry

Psychedelics News

Breaking News

Breaking News, Industry

21 Nov 2024

MAPS Successfully Clears Path for Cannabis Research through FDA Formal Dispute

After years of regulatory hurdles, MAPS has secured FDA clearance to study cannabis for PTSD in a real-world context. This groundbreaking trial focuses on veterans and aims to provide high-quality...

By Madison Roberts

Breaking News, Don’t Miss, Health & Wellness, Industry

4 Nov 2024

SoundSelf’s Wefunder Campaign: Bringing Digital Psychedelics to Mental Health Providers

SoundSelf, the groundbreaking digital therapeutics company, is launching a community investment campaign on Wefunder. This Austin-based innovator aims to revolutionize mental health care by using immersive technology to support mental...

By Madison Roberts

Breaking News, Press Releases

15 Oct 2024

Enveric Biosciences Unveils Positive Safety and Pharmacology Data for EB-003

New preclinical results showcase EB-003’s ability to target serotonergic receptors while minimizing risks of cardiovascular and CNS side effects, advancing its potential as a non-hallucinogenic treatment for mental health disorders....

By Madison Roberts

Breaking News

25 Sep 2024

Enveric Biosciences Presents Data on Lead Product Candidate, EB-003, at 7th Neuropsychiatric Drug Summit

Enveric Biosciences presented promising preclinical data on their lead drug candidate, EB-003, at the 7th Neuropsychiatric Drug Summit. This non-hallucinogenic, neuroplastogenic DMT analog demonstrated significant reductions in anxiety and depression...

By Madison Roberts

Join Our Newsletter for Exclusive Updates, Stories, and More

Breaking News

6 Sep 2024

Psyence Biomed Announces Acquisition of Psilocybin Drug Developer Clairvoyant Therapeutics

Psyence Biomed announces acquisition Clairvoyant Therapeutics and its Phase 2b trial...

By Microdose NewsDesk

Breaking News

13 Aug 2024

FDA Rejected MDMA-Assisted PTSD Therapy: Psychedelic Industry Responds

The FDA's recent rejection of MDMA-assisted therapy for PTSD has sparked significant reactions from the psychedelic and mental health communities. While the decision is seen as a setback, industry leaders...

By Madison Roberts

Breaking News

5 Jun 2024

FDA Advisory Committee Rejects Lykos’ MDMA Therapy For PTSD

An FDA advisory panel has rejected the approval of MDMA as a treatment for post-traumatic stress disorder (PTSD). The FDA’s Psychopharmacologic Drugs Advisory Committee (PDAC) met to review Lykos Therapeutics’...

By Jason Najum

Breaking News

14 May 2024

Advancing Mental Health Treatments: The Strategic Collaboration Between Enveric Biosciences and MindBio Therapeutics

In a groundbreaking move within the pharmaceutical industry, Enveric Biosciences (NASDAQ: ENVB) a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety,...

By Madison Roberts

Breaking News, Press Releases

13 May 2024

AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders

AbbVie and Gilgamesh Pharmaceuticals today announced a collaboration and option-to-license agreement to develop next-generation therapies for psychiatric disorders. This collaboration will leverage AbbVie's expertise in psychiatry and Gilgamesh's innovative research...

By Madison Roberts

Follow us on social

Latest News

Reading the Brain’s Response: Enveric’s EB-003 Takes a Step Toward Human Testing

The Cost of Waiting: What Compass’s Depression Survey Means for Psychedelic Medicine

Beyond the Psychedelic Experience: Enveric Biosciences Takes Another Step Toward a New Generation of Mental Health Treatments

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result